Clinical trial Recruiting at 5 sites Interventional Ages 14 to 17

Prevention program for addictive behaviors in vulnerable teenagers

Official title: Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers

Run by University Hospital, Brest · NCT04599270 · Data updated 2026-11-12

This study tests a new program that helps teenagers aged 14 to 17 in Brittany learn about the dangers of alcohol and offers support to prevent them from developing drinking problems.

Quick facts

Study typeInterventional
Ages14 Years to 17 Years
SexAll
Enrollment700 (estimated)
SponsorUniversity Hospital, Brest
Academic / other
Locations5 sites (Brest and 4 other locations)
StatusRecruiting
StartedOctober 1, 2021
Main results expectedOctober 1, 2026
Study endsOctober 1, 2027
Registry record updatedJune 10, 2026
Trial IDNCT04599270 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this program are adolescents aged 14 to 17 who have experimented with alcohol and are seeking support.

Probably not a fit

Patients with moderate to severe substance use disorders or significant psychiatric conditions may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to address the rising rates of alcohol consumption among adolescents aged 14 to 17 in Brittany by implementing a dedicated prevention strategy. The PREVENTURE program focuses on educating teenagers about the risks of alcohol use and providing support to reduce the likelihood of developing substance use disorders. Participants will receive routine care alongside the intervention, which is designed to be accessible through digital platforms. The study seeks to gather reliable data on the effectiveness of this prevention approach in a school setting.

Why it matters

Potential benefit: If successful, this program could significantly reduce the incidence of alcohol use and related disorders among teenagers.

How similar studies have gone: Previous studies on school-based prevention programs have shown limited effectiveness, highlighting the need for innovative approaches like PREVENTURE.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 14 and 17 years old
* Patient consulting in one of the participating centres or referred by a school doctor
* Patient who has had at least one previous experience with alcohol (at least 1 standard unit of alcohol, once in their lifetime)
* Having access to an internet network and a computer, tablet or telephone
* Written and informed consent of the parents and the teenager

Exclusion Criteria:

* Refusal to participate in the study
* Moderate to Severe Adolescent Substance Use Disorders (other than smoking)
* Decompensated current psychiatric disorders in adolescents
* Already followed for severe use disorders and/or severe psychiatric disorders
* Nonunderstanding of the french language

Where it's running

  • Loik JOUSNI
    Brest, France
    Recruiting
  • Morgane GUILLOU - LANDREAT
    Brest, France
    Recruiting
  • Pascale ROZEC
    Landerneau, France
    Recruiting
  • Catherine SIMON
    Morlaix, France
    Recruiting
  • Benoit SCHRECK
    Nantes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Brain imaging to predict teens' response to cannabis treatment

    This project will test whether teens' brain activity during a learning task can predict how well 14–17-year-olds do in a 10-week virtual reward program to reduce cannabis use.

    Recruiting Indiana University · Indianapolis, Indiana · NCT07340554

  • Validation of the French version of the PAWSS scale for alcohol withdrawal prediction

    This study is testing a French version of a scale to see if it can accurately predict alcohol withdrawal symptoms in people with alcohol use disorders who are in the hospital.

    Recruiting Etablissement Public de Santé Barthélemy Durand · Étampes · NCT06675539

  • Understanding stress responses in individuals with alcohol use disorder

    This study looks at how people with alcohol use disorder react to stress and whether these reactions affect their cravings and drinking habits over time.

    Recruiting at 2 sites Central Institute of Mental Health, Mannheim · Mannheim, Baden-Wurttemberg and 1 other locations · NCT06105853

  • Evaluating the impact of pain management on patients' lives

    This study looks at how pain management services can improve the lives of adults with chronic pain by checking their health, social life, and job situation.

    Recruiting Salem Anaesthesia Pain Clinic · Surrey, British Columbia · NCT06076512

  • High dose stimulant treatment for methamphetamine users

    This study is testing whether a high dose of a medication called lisdexamfetamine, along with support and rewards, can help adults who use methamphetamine reduce their drug use more effectively than standard treatment alone.

    Recruiting at 3 sites Phase 2 Centre hospitalier de l'Université de Montréal (CHUM) · Vancouver, British Columbia and 3 other locations · NCT05854667

  • Parenting program for families affected by alcohol use disorders

    This study is testing a parenting program to see if it can help families with a parent who has an alcohol use disorder improve their parenting skills and strengthen family relationships.

    Recruiting University Hospital, Brest · Brest · NCT05490589

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.